$1.32 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 113 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 146.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OCDX | New | ORTHO CLINICAL DIAGNOSTICS H | $33,390,000 | – | 1,730,500 | +100.0% | 2.53% | – |
| ARQT | New | ARCUTIS BIOTHERAPEUTICS INC | $25,428,000 | – | 878,948 | +100.0% | 1.93% | – |
| TGTX | Buy | TG THERAPEUTICS INC | $24,758,000 | +130.4% | 513,649 | +148.7% | 1.88% | +148.0% |
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $24,393,000 | -22.2% | 257,879 | +0.2% | 1.85% | -16.3% |
| RGEN | Buy | REPLIGEN CORP | $24,242,000 | +1.9% | 124,693 | +0.4% | 1.84% | +9.6% |
| ALHC | New | ALIGNMENT HEALTHCARE INC | $23,092,000 | – | 1,052,987 | +100.0% | 1.75% | – |
| VOR | New | VOR BIOPHARMA INC | $23,070,000 | – | 535,259 | +100.0% | 1.75% | – |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $22,320,000 | -9.2% | 321,659 | +0.5% | 1.69% | -2.4% |
| NVTA | New | INVITAE CORP | $21,923,000 | – | 573,759 | +100.0% | 1.66% | – |
| ACCD | New | ACCOLADE INC | $21,358,000 | – | 470,750 | +100.0% | 1.62% | – |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $19,873,000 | -1.4% | 447,885 | +21.9% | 1.51% | +6.1% |
| OSH | Buy | OAK STR HEALTH INC | $19,062,000 | +24.7% | 351,250 | +40.5% | 1.44% | +34.2% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $17,455,000 | -50.7% | 1,766,704 | +15.1% | 1.32% | -47.0% |
| A | New | AGILENT TECHNOLOGIES INC | $15,765,000 | – | 124,000 | +100.0% | 1.20% | – |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $15,495,000 | +10.0% | 109,746 | +1.3% | 1.18% | +18.4% |
| OLK | New | OLINK HLDG ABsponsored ads | $15,307,000 | – | 425,198 | +100.0% | 1.16% | – |
| RMD | Buy | RESMED INC | $14,766,000 | +4.8% | 76,105 | +14.8% | 1.12% | +12.7% |
| QTRX | New | QUANTERIX CORP | $14,248,000 | – | 243,689 | +100.0% | 1.08% | – |
| MRTX | Buy | MIRATI THERAPEUTICSmirati therapeutics inc | $13,547,000 | -16.2% | 79,081 | +7.4% | 1.03% | -9.9% |
| COO | New | COOPER COS INC | $13,328,000 | – | 34,700 | +100.0% | 1.01% | – |
| HARP | New | HARPOON THERAPEUTICS INC | $13,202,000 | – | 631,050 | +100.0% | 1.00% | – |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $13,113,000 | +1792.2% | 142,475 | +1403.7% | 0.99% | +1928.6% |
| NTRA | Buy | NATERA INC | $13,083,000 | +49.5% | 128,850 | +46.5% | 0.99% | +60.8% |
| RARE | New | ULTRAGENYX PHARMACEUTICAL IN | $12,775,000 | – | 112,200 | +100.0% | 0.97% | – |
| INSM | New | INSMED INC | $12,609,000 | – | 370,200 | +100.0% | 0.96% | – |
| INSP | New | INSPIRE MED SYS INC | $12,523,000 | – | 60,500 | +100.0% | 0.95% | – |
| INNV | New | INNOVAGE HLDG CORP | $12,374,000 | – | 479,794 | +100.0% | 0.94% | – |
| PODD | Buy | INSULET CORP | $12,356,000 | +13.3% | 47,354 | +11.0% | 0.94% | +22.0% |
| HOLX | Buy | HOLOGIC INC | $12,109,000 | +5.0% | 162,800 | +2.8% | 0.92% | +13.1% |
| FATE | Buy | FATE THERAPEUTICS INC | $11,749,000 | +30.5% | 142,500 | +43.9% | 0.89% | +40.5% |
| BBIO | Buy | BRIDGEBIO PHARMA INC | $11,279,000 | +2541.5% | 183,100 | +2951.7% | 0.86% | +2750.0% |
| EPIX | New | ESSA PHARMA INC | $10,806,000 | – | 371,963 | +100.0% | 0.82% | – |
| BOLT | New | BOLT BIOTHERAPEUTICS INC | $10,532,000 | – | 320,010 | +100.0% | 0.80% | – |
| TIL | New | INSTIL BIO INC | $9,461,000 | – | 377,250 | +100.0% | 0.72% | – |
| LUNG | New | PULMONX CORP | $9,281,000 | – | 202,900 | +100.0% | 0.70% | – |
| CTLT | New | CATALENT INC | $8,241,000 | – | 78,250 | +100.0% | 0.62% | – |
| MTEM | Buy | MOLECULAR TEMPLATES INC | $7,780,000 | +269.1% | 616,450 | +174.6% | 0.59% | +296.0% |
| EXAS | New | EXACT SCIENCES CORP | $7,248,000 | – | 55,000 | +100.0% | 0.55% | – |
| MEIP | New | MEI PHARMA INC | $6,729,000 | – | 1,961,667 | +100.0% | 0.51% | – |
| FNCH | New | FINCH THERAPEUTICS GROUP INC | $6,299,000 | – | 390,000 | +100.0% | 0.48% | – |
| MDT | Buy | MEDTRONIC PLC | $6,202,000 | +37.5% | 52,501 | +36.4% | 0.47% | +47.8% |
| VIRX | New | VIRACTA THERAPEUTICS INC | $5,990,000 | – | 647,556 | +100.0% | 0.45% | – |
| NKTX | New | NKARTA INC | $5,562,000 | – | 169,050 | +100.0% | 0.42% | – |
| NCNA | Buy | NUCANA PLCsponsored adr | $5,563,000 | +65.2% | 1,114,801 | +48.6% | 0.42% | +78.1% |
| TLIS | New | TALIS BIOMEDICAL CORP | $5,205,000 | – | 405,094 | +100.0% | 0.40% | – |
| ONCR | New | ONCORUS INC | $4,663,000 | – | 335,000 | +100.0% | 0.35% | – |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $3,970,000 | +119.8% | 102,726 | +104.5% | 0.30% | +137.0% |
| DHR | Buy | DANAHER CORPORATION | $3,776,000 | +126.7% | 16,775 | +123.7% | 0.29% | +144.4% |
| CYRX | New | CRYOPORT INC | $3,486,000 | – | 67,034 | +100.0% | 0.26% | – |
| SYK | Buy | STRYKER CORP | $3,337,000 | +74.6% | 13,700 | +75.6% | 0.25% | +87.4% |
| PSNL | New | PERSONALIS INC | $2,966,000 | – | 120,500 | +100.0% | 0.22% | – |
| SHC | Buy | SOTERA HEALTH CO | $2,256,000 | +10.2% | 90,368 | +21.1% | 0.17% | +18.8% |
| BGNE | New | BEIGENE LTDsponsored adr | $2,019,000 | – | 5,800 | +100.0% | 0.15% | – |
| ILMN | Buy | ILLUMINA INC | $1,598,000 | +6.1% | 4,160 | +2.2% | 0.12% | +14.2% |
| ZLAB | Buy | ZAI LAB LTDadr | $787,000 | +49.1% | 5,900 | +51.3% | 0.06% | +62.2% |
| GBIO | New | GENERATION BIO CO | $613,000 | – | 21,522 | +100.0% | 0.05% | – |
| ALVR | Buy | ALLOVIR INC | $502,000 | +33.9% | 21,450 | +120.1% | 0.04% | +46.2% |
| ASND | New | ASCENDIS PHARMA A/Ssponsored adr | $419,000 | – | 3,250 | +100.0% | 0.03% | – |
| OLMA | New | OLEMA PHARMACEUTICALS INC | $428,000 | – | 12,900 | +100.0% | 0.03% | – |
| RPTX | New | REPARE THERAPEUTICS INC | $307,000 | – | 10,000 | +100.0% | 0.02% | – |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $299,000 | – | 10,300 | +100.0% | 0.02% | – |
| COGT | New | UNUM THERAPEUTICS INC | $237,000 | – | 27,000 | +100.0% | 0.02% | – |
| GTH | New | GENETRON HLDGS LTDads | $232,000 | – | 10,800 | +100.0% | 0.02% | – |
| DNLI | New | DENALI THERAPEUTICS INC | $228,000 | – | 4,000 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.